CD4 and neoplasm: Consistent with previous reports, we find a strong correlation between the induction of CD8+ and CD4+ reactive T cells by APC-targeted DNA vaccines and anti-tumor efficacy, indicating that neoepitope-induced T-cells mediate the anti-tumor effect (33).